Project no.: HIV-NAT 166.1
This is a prospective study that will compare and contrast the impact that HIV/HCV co-infected and HCV mono-infected has on Cognitive Function, Mood, Health-Related Quality of Life (HRQOL), pre, during and post treatment with pegylated interferon/ribavirin success.